TREA

88776175 - ILIAS THERAPEUTICS

Follow

Information

  • Trademark
  • 88776175
  • Serial Number
    88776175
  • Registration Number
    7033391
  • Filing Date
    January 28, 2020
    4 years ago
  • Registration Date
    April 25, 2023
    a year ago
  • Transaction Date
    April 25, 2023
    a year ago
  • Status Date
    April 25, 2023
    a year ago
  • Published for Opposition Date
    February 07, 2023
    a year ago
  • Location Date
    April 25, 2023
    a year ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    FALK, ERIN M
  • Attorney Docket Number
    TK0171676
    Attorney Name
    Jae Youn Kim
    Law Office Assigned Location Code
    L10
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
ILIAS THERAPEUTICS
Case File Statements
  • GS0091: Electric bio-sensors; glassware for laboratory scientific experiments; incubator for laboratory use in cell culture; laboratory equipment, namley, protein sequence analysis equipment being laboratory apparatus; nucleic acid sequencers for scientific purposes for use in analyzing nucleic acide; petri dishes for laboratory use used in cell culture; bioreactor for cell culturing; apparatus for analyzing biochips for laboratory use; laboratory centrifuges; cell culture apparatus for laboratory use, namely, bioreactor for cell culturing; probes for scientific purposes; physical and chemical laboratory apparatus and instruments, namley, apparatus and instruments for cell culturing; particle foreign substances detectors for laboratory use, namely, detectors used in cell culturing; ultrasonic sensors for molecular biology research in the nature of sensors used in cell culturing; bioreactors for laboratory use; microscopes for medical use; laboratory chemical reactors
  • N00000: The name(s), portrait(s), and/or signature(s) shown in the mark does not identify a particular living individual.
  • GS0051: Biochemicial drug for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; diagnostic reagents for medical purposes; pharmaceutical preparations for treating cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; stem cells for veterinary purposes; nutraceutical preparations for therapeutic or medical purposes for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; chemical preparations for pharmaceutical purposes for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; enzyme preparations for medical purposes; chemical preparations for medical purposes for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; diagnostic preparations for medical purposes; chemico-pharmaceutical preparations for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; chemical reagents for medical or veterinary purposes; preparations of microorganisms for medical and veterinary use for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; genetic identity tests comprised of reagents for medical purposes; biological preparations for medical purposes for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; biological preparations for veterinary purposes for the treatment of cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; bacteriological preparations for medical and veterinary use; biological reagents for clinical medical use; stem cells for medical purposes; drugs for medical purposes featuring drugs for the purpose of treating cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; medicines for human purposes featuring medicines for the purpose of treating cancer, metabolic disease, inflammatory disease, genetic disease, infectious diseases, cardiovascular disease, respiratory disease, neurological disease, auto-immune disease, fibrosis disease; pharmaceutical preparations for the treatment of immune system related diseases and disorders; cell therapeutics for medical use
  • GS0351: Retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; retail and wholesale store services featuring drugs; retail and wholesale store services featuring veterinary drugs; retail and wholesale store services featuring pharmaceutical preparations; retail and wholesale store services featuring health preparations; retail and wholesale store services featuring medical supplies; retail and wholesale store services featuring preparations for veterinary use; sales promotion for others; marketing services
  • GS0011: Diagnostic reagents and preparations, other than for medical or veterinary use; biologics in the nature of biological preparations for use in cell cultures, other than for medical or veterinary use; chemical preparations for scientific purposes, other than for medical or veterinary use; biochemical catalysts; biological preparations for use in industry and science, other than for medical or veterinary purposes; bacterial preparations other than for medical and veterinary use; bacteriological preparations other than for medical and veterinary use; cultures of microorganisms, other than for medical and veterinary use; industrial chemicals; diagnostic preparations, other than for medical or veterinary purposes; biological tissue cultures other than for medical or veterinary purposes; preparations of microorganisms, other than for medical and veterinary use; adjuvants, other than for medical or veterinary purposes; reagent paper, other than for medical or veterinary purposes; stem cells other than for medical or veterinary purposes; chemical reagents, other than for medical or veterinary purposes
  • D10000: "THERAPEUTICS"
  • GS0421: Research and development of technology for biotechnology in the nature of cell biology; biomedical research services; technological research in the field of cell biology; scientific research; biological research; laboratory research in the field of cell biology; scientific research and development; biological research and analysis; biotechnological research; cell separation research services; pharmaceutical drug development services; development of pharmaceutical preparations and medicines; medical research; laboratory research in the field of pharmaceuticals; genetic testing for scientific research purposes; structural and functional analysis of genomes; medical laboratory services; stem cell research services; scientific laboratory services
Case File Event Statements
  • 4/25/2023 - a year ago
    44 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 4/25/2023 - a year ago
    43 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 2/7/2023 - a year ago
    42 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 2/7/2023 - a year ago
    41 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 1/18/2023 - a year ago
    40 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 12/20/2022 - a year ago
    39 - CASE RETURNED TO EXAMINATION Type: OTHE
  • 12/20/2022 - a year ago
    38 - NOTICE OF ALLOWANCE CANCELLED Type: IUCN
  • 12/19/2022 - a year ago
    37 - PETITION TO DIRECTOR - CHANGE BASIS - GRANTED Type: PCBG
  • 12/19/2022 - a year ago
    36 - TEAS RESPONSE TO PETITION TO DIRECTOR INQUIRY Type: ERTI
  • 11/28/2022 - 2 years ago
    35 - PETITION INQUIRY LETTER ISSUED Type: PILM
  • 12/17/2022 - a year ago
    34 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 12/15/2022 - a year ago
    33 - SOU EXTENSION 3 GRANTED Type: EX3G
  • 12/15/2022 - a year ago
    32 - SOU EXTENSION 3 FILED Type: EXT3
  • 12/15/2022 - a year ago
    31 - TEAS EXTENSION RECEIVED Type: EEXT
  • 11/21/2022 - 2 years ago
    30 - ASSIGNED TO PETITION STAFF Type: APET
  • 11/6/2022 - 2 years ago
    29 - TEAS PETITION TO AMEND BASIS RECEIVED Type: TPAD
  • 6/17/2022 - 2 years ago
    28 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 6/15/2022 - 2 years ago
    27 - SOU EXTENSION 2 GRANTED Type: EX2G
  • 6/15/2022 - 2 years ago
    26 - SOU EXTENSION 2 FILED Type: EXT2
  • 6/15/2022 - 2 years ago
    25 - TEAS EXTENSION RECEIVED Type: EEXT
  • 12/17/2021 - 2 years ago
    24 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 12/15/2021 - 2 years ago
    23 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 12/15/2021 - 2 years ago
    22 - SOU EXTENSION 1 FILED Type: EXT1
  • 12/15/2021 - 2 years ago
    21 - TEAS EXTENSION RECEIVED Type: EEXT
  • 6/15/2021 - 3 years ago
    20 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 5/2/2021 - 3 years ago
    19 - EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Type: ETOP
  • 1/8/2021 - 3 years ago
    18 - EXTENSION OF TIME TO OPPOSE RECEIVED Type: ETOF
  • 12/22/2020 - 3 years ago
    17 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 12/22/2020 - 3 years ago
    16 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 12/2/2020 - 4 years ago
    15 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 11/18/2020 - 4 years ago
    14 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 11/18/2020 - 4 years ago
    13 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 11/18/2020 - 4 years ago
    12 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 11/18/2020 - 4 years ago
    11 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 11/18/2020 - 4 years ago
    10 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 10/27/2020 - 4 years ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 10/27/2020 - 4 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 10/27/2020 - 4 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 4/27/2020 - 4 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 4/27/2020 - 4 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 4/27/2020 - 4 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 4/16/2020 - 4 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 2/3/2020 - 4 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 1/31/2020 - 4 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP